Fulton Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
11,794
-931
-7% -$123K 0.05% 263
2026
Q1
$1.77M Sell
12,725
-9,171
-42% -$1.28M 0.06% 209
2025
Q4
$2.69M Buy
21,896
+5,968
+37% +$725K 0.09% 156
2025
Q3
$1.77M Sell
15,928
-5,098
-24% -$579K 0.06% 206
2025
Q2
$2.33M Sell
21,026
-9,389
-31% -$999K 0.09% 166
2025
Q1
$3.41M Sell
30,415
-3,622
-11% -$374K 0.14% 109
2024
Q4
$3.14M Sell
34,037
-3,518
-9% -$317K 0.12% 124
2024
Q3
$3.15M Buy
37,555
+5,055
+16% +$386K 0.12% 125
2024
Q2
$2.23M Buy
32,500
+1,007
+3% +$67.2K 0.09% 162
2024
Q1
$2.31M Buy
31,493
+12,775
+68% +$982K 0.09% 162
2023
Q4
$1.52M Sell
18,718
-171
-0.9% -$13.3K 0.07% 211
2023
Q3
$1.42M Buy
18,889
+678
+4% +$52.1K 0.07% 206
2023
Q2
$1.4M Sell
18,211
-10,710
-37% -$854K 0.07% 205
2023
Q1
$2.4M Sell
28,921
-29,866
-51% -$2.47M 0.13% 139
2022
Q4
$5.05M Sell
58,787
-598
-1% -$47.4K 0.28% 64
2022
Q3
$3.66M Buy
59,385
+711
+1% +$44.8K 0.22% 82
2022
Q2
$3.63M Buy
58,674
+6,631
+13% +$411K 0.2% 86
2022
Q1
$3.09M Buy
52,043
+7,319
+16% +$468K 0.14% 113
2021
Q4
$3.25M Sell
44,724
-686
-2% -$47.2K 0.14% 111
2021
Q3
$3.17M Sell
45,410
-641
-1% -$45K 0.15% 105
2021
Q2
$3.17M Sell
46,051
-2,334
-5% -$156K 0.15% 107
2021
Q1
$3.13M Sell
48,385
-6,380
-12% -$411K 0.16% 104
2020
Q4
$3.19M Buy
54,765
+11,303
+26% +$682K 0.17% 98
2020
Q3
$2.75M Buy
43,462
+20,825
+92% +$1.44M 0.17% 101
2020
Q2
$1.74M Sell
22,637
-46,805
-67% -$3.59M 0.11% 137
2020
Q1
$5.19M Buy
69,442
+2,533
+4% +$175K 0.41% 53
2019
Q4
$4.35M Buy
66,909
+85
+0.1% +$5.54K 0.27% 73
2019
Q3
$4.24M Buy
66,824
+31,050
+87% +$2.03M 0.29% 73
2019
Q2
$2.42M Sell
35,774
-2,591
-7% -$170K 0.16% 112
2019
Q1
$2.49M Sell
38,365
-3,836
-9% -$255K 0.17% 110
2018
Q4
$2.64M Sell
42,201
-8,193
-16% -$573K 0.21% 96
2018
Q3
$3.89M Sell
50,394
-6,828
-12% -$516K 0.26% 78
2018
Q2
$4.05M Buy
57,222
+42
+0.1% +$2.97K 0.28% 68
2018
Q1
$4.31M Buy
57,180
+7,961
+16% +$633K 0.3% 62
2017
Q4
$3.53M Sell
49,219
-938
-2% -$71.2K 0.25% 78
2017
Q3
$4.06M Buy
50,157
+2,391
+5% +$183K 0.3% 65
2017
Q2
$3.38M Buy
47,766
+4,337
+10% +$289K 0.26% 75
2017
Q1
$2.95M Buy
43,429
+3,253
+8% +$229K 0.24% 83
2016
Q4
$2.88M Sell
40,176
-525
-1% -$39K 0.25% 81
2016
Q3
$3.22M Sell
40,701
-3,162
-7% -$257K 0.3% 73
2016
Q2
$3.66M Buy
43,863
+2,947
+7% +$262K 0.36% 65
2016
Q1
$3.76M Sell
40,916
-2,444
-6% -$220K 0.38% 56
2015
Q4
$4.39M Buy
43,360
+5,133
+13% +$534K 0.46% 48
2015
Q3
$3.75M Buy
38,227
+1,444
+4% +$160K 0.42% 52
2015
Q2
$4.31M Sell
36,783
-244
-0.7% -$26.7K 0.45% 43
2015
Q1
$3.63M Buy
37,027
+1,097
+3% +$111K 0.38% 48
2014
Q4
$3.39M Sell
35,930
-600
-2% -$62.1K 0.38% 54
2014
Q3
$3.89M Sell
36,530
-3,248
-8% -$318K 0.44% 42
2014
Q2
$3.3M Sell
39,778
-7,711
-16% -$600K 0.37% 58
2014
Q1
$3.37M Sell
47,489
-928
-2% -$72.8K 0.39% 53
2013
Q4
$3.64M Sell
48,417
-15,675
-24% -$1.09M 0.43% 50
2013
Q3
$4.03M Sell
64,092
-2,967
-4% -$177K 0.47% 47
2013
Q2
$3.44M Buy
+67,059
New +$3.5M 0.43% 58

Other funds holding GILD

Fulton Bank's GILD Position: Q2 2026 in Review

Fulton Bank reduced its Gilead Sciences (GILD) stake by 7.3% in Q2 2026, selling an estimated $123K and leaving 11,794 shares worth $1.49M. The position accounts for 0.05% of the portfolio, ranked #263.

Fulton Bank first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.19M in Q1 2020. 425 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fulton Bank held 11,794 shares of Gilead Sciences worth $1.49M as of Q2 2026.
  • Fulton Bank sold 931 Gilead Sciences shares in Q2 2026, an estimated $123K.
  • Gilead Sciences made up 0.05% of Fulton Bank's portfolio in Q2 2026, its #263 holding.
  • Fulton Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Fulton Bank's Gilead Sciences position peaked at $5.19M in Q1 2020.
  • 425 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.